hyosuk87 I'm not much of a trader more of a medium term holder/investor but the trading pattern still displays a pennant, lower highs, higher lows etc. In the medium term PRR has the finance to move forward with its plans regardless of the day to day share price movement. The biotech sector is buoyant and cancer vaccine stocks are the pick of the crop atm. I have no reason to be concerned at this stage we will only have positive announcement to come imho. The spp at .07cents and the US partners announcement will keep traders interested and it may not be until the final week of the spp that we here something positive in the short term. Imo the FDA approving the IND application will really set the wheels in motion for Prima. I'm really looking forward to that outcome.Cheers
bottom trendline passes through .063cents
PRR Price at posting:
5.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)